Valuation: BICO Group AB

Market Cap 169.73Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.62TCr 24Cr 67Cr 850.38Cr 64Cr 63Cr 2.68TCr P/E 2026 *
-22.9x
P/E 2027 * -11.7x
Enterprise Value 152.83Cr 15Cr 14Cr 13Cr 12Cr 22Cr 1.46TCr 22Cr 61Cr 765.71Cr 58Cr 57Cr 2.41TCr EV / Sales 2026 *
0.92x
EV / Sales 2027 * 0.9x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 day+0.84%
1 week-0.82%
Current month+10.07%
1 month+6.89%
3 months+80.83%
6 months+19.65%
Current year+14.20%
1 week 23.5
Extreme 23.5
24.6
1 month 21.05
Extreme 21.05
25.35
Current year 12.94
Extreme 12.94
25.35
1 year 12.94
Extreme 12.94
25.42
3 years 12.94
Extreme 12.94
72.3
5 years 12.94
Extreme 12.94
500
10 years 9
Extreme 9
630
Manager TitleAgeSince
Chief Executive Officer 51 01/09/2026
Director of Finance/CFO 56 01/03/2026
Chief Operating Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 71 18/12/2019
Director/Board Member 37 01/03/2015
Director/Board Member 51 07/05/2026
Date Insider Type Main position Quantity % Market Cap. Importance
21/08/26 Buy

Director

15,000 0.0217%
30/04/26 Buy

Director

25,000 0.0362%
30/04/26 Buy

Chief Operating Officer

10,000 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-0.82%+5.58%-11.12% 17Cr
-0.40%-2.34%+17.82%+45.91% 25TCr
+0.33%+0.64%+3.49%+12.96% 16TCr
+1.90%+6.00%-17.96%+65.92% 15TCr
-0.70%+2.93%-55.38%-8.86% 6.67TCr
+0.24%+0.99%-15.19%-10.88% 5.21TCr
+0.15%+4.09%+10.82%+65.55% 5.22TCr
-1.13%+2.85%+16.39%+28.99% 5.19TCr
-0.47%+0.06%+17.37%+58.29% 4.9TCr
-0.42%+3.83%+27.55%+77.45% 4.48TCr
Average +0.03%+1.75%+1.05%+32.42% 8.83TCr
Weighted average by Cap. +0.13%+1.49%+1.45%+38.32%

Financials

2026 *2027 *
Net sales 166.2Cr 17Cr 15Cr 14Cr 13Cr 23Cr 1.59TCr 24Cr 66Cr 832.68Cr 63Cr 61Cr 2.63TCr 164.25Cr 17Cr 15Cr 14Cr 12Cr 23Cr 1.57TCr 24Cr 65Cr 822.91Cr 62Cr 61Cr 2.59TCr
Net income -7.4Cr -74.54L -66.57L -61.49L -55.73L -1.04Cr -71Cr -1.06Cr -2.93Cr -37Cr -2.8Cr -2.74Cr -116.89Cr -14Cr -1.45Cr -1.3Cr -1.2Cr -1.08Cr -2.03Cr -137.7Cr -2.06Cr -5.7Cr -72Cr -5.44Cr -5.33Cr -227.45Cr
Net Debt -17Cr -1.7Cr -1.52Cr -1.4Cr -1.27Cr -2.38Cr -161.61Cr -2.42Cr -6.69Cr -85Cr -6.39Cr -6.25Cr -266.94Cr -23Cr -2.29Cr -2.04Cr -1.89Cr -1.71Cr -3.2Cr -217.07Cr -3.25Cr -8.99Cr -113.73Cr -8.58Cr -8.4Cr -358.56Cr
Projected Income Statement - Annual - BICO Group AB
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
554
Date Price Change Volume
23/26/23 SEK 24.05 +0.84% 1,10,699
22/26/22 SEK 23.85 -0.62% 1,59,583
21/26/21 SEK 24.00 +1.27% 1,12,391
20/26/20 SEK 23.70 -1.66% 1,89,599
19/26/19 SEK 24.10 -0.62% 2,35,880
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BICO Group AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
24.05SEK
Average target price
31.00SEK
Spread / Average Target
+28.90%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BICO Group AB
  1. Stock Market
  2. Stocks
  3. BICO Stock